Concussion mTBI: The Science Behind mTBI
Tracks
Room: 520BC
Wednesday, March 19, 2025 |
8:15 AM - 12:15 PM |
Room: 520BC |
Details
CME
Speaker
Dr. Haley Chizuk
University at Buffalo
Session Chair: Concussion-mTBI: The Science Behind mTBI
Biography
Dr. Haley Chizuk is a researcher in the Concussion Management Lab at the University at Buffalo. Her research interests include fluid biomarkers, concussion, and aerobic exercise treatment. In addition to her research, she is an active athletic trainer in the greater Buffalo community, providing direct care to local athletes.
Dr. John Leddy
SUNY Buffalo
ANS
Biography
Dr. Haley Chizuk
University at Buffalo
Fluid Biomarkers
Biography
Dr. M Nadir Haider
University at Buffalo, SUNY
DBF, DTI
Biography
Dr Haider is a Research Assistant Professor and the Assistant Director or Research at the UBMD Concussion Management Clinic and Research Center. His clinical research is focused on concussion-related exercise intolerance and how to use prescribed aerobic exercise for treatment and his pre-clinical research is focused on identifying biofluid and physiological biomarkers for concussion diagnosis and recovery.
Ms. Elizabeth Castro
The State University of New York at Buffalo
MRI Part 1, the Basics
Biography
Dr. Joshua P. McGeown
Matai Medical Research Institute
MRI Part 2, In-Depth
Biography
Dr Josh McGeown is a Senior Research Fellow at Mātai Medical Research Institute supported by the Neurological Foundation First Fellowship. Josh’s passion for mTBI research comes from personal experience with the negative consequences of this injury. His work has focussed on understanding how pathophysiological consequences of mTBI underlie clinical symptoms and outcomes to identify targets for better prevention, assessment, and rehabilitation. Josh has a diverse inter-discipline skillset spanning clinical experience to advanced statistical analysis including machine learning. Josh’s work at Mātai focusses on how advanced multimodal MRI can create a complete picture of the brain’s state after mTBI and how changes in this state explain subjective symptom reports over the recovery period. This work may lead to an imaging-based clinical support tool that could transform patient-centred management of mTBI.
